Lacticaseibacillus rhamnosus HF01 fermented yogurt alleviated high-fat diet-induced obesity and hepatic steatosis via the gut microbiota–butyric acid–hepatic lipid metabolism axis

Yue Sun, Xiaolin Liu, Rongchun Wang, Rongmei Liu, Xuepeng Lv, Ying Ma and Qiming Li

Food Funct., 2024, 15, 4475
DOI: 10.1039/D3FO04985J

Cirsiliol alleviates experimental inflammatory bowel disease via restoration of intestinal barrier integrity and inhibition of NF-κB and MAPK pathways

Juan Gao, Haiyang Li, Zhenquan Wang, Gufen Jiang, Liao Pan, Zhengxuan Jiang and Xiaohong Lei

Sci Rep, 2025, 15
DOI: 10.1038/s41598-025-09896-x

Mechanisms of action of natural plant-derived bioactive compounds in treating intestinal tight junctions dysfunction

Jiduo Han, Ziliang Xiao, Lingyu Yang, Jianfang Feng, Yi Jin, Meng Cheng and Liangxing Tu

Phytochem Rev, 2026
DOI: 10.1007/s11101-026-10242-w

Tanshinone IIA Inhibits the Endoplasmic Reticulum Stress-Induced Unfolded Protein Response by Activating the PPARα/FGF21 Axis to Ameliorate Nonalcoholic Steatohepatitis

Dajin Pi, Zheng Liang, Jinyue Pan, Jianwei Zhen, Chuiyang Zheng, Wen Fan, Qingliang Song, Maoxing Pan, Qinhe Yang and Yupei Zhang

Antioxidants, 2024, 13, 1026
DOI: 10.3390/antiox13091026

Intestinal barrier defense: the protective effect of plant-based traditional Chinese medicine

Shaofeng Wu, Yu Ga, Danyang Ma, Silu Hou, Qiaoyue Hui and Zhihui Hao

One Health Adv., 2026, 4
DOI: 10.1186/s44280-026-00117-2

From Bench to Bedside: Multifunctional Nanoplatforms in the Fight Against Non-alcoholic Fatty Liver Disease

Yu Zhao, Luting Wang, Shengrui Zhu, Rui Feng and Wei Zhang

IJN, 2026, Volume 21, 1
DOI: 10.2147/IJN.S593450

Ethanol extract of Polygonatum cyrtonema Hua mitigates non-alcoholic steatohepatitis in mice

Dongliang Chen, Yue Shen, Fang Huang, Bo Huang, Shangfu Xu, Lisheng Li, Jie Liu, Zheng Li and Xia Li

Front. Pharmacol., 2025, 15
DOI: 10.3389/fphar.2024.1487738

An efficient design strategy for flavonoid co-amorphous systems and enhanced their antioxidant and antibacterial activities for application potential in food preservation and functional products

Jiawei Han, Wen Sun, Weitao Fang, Zhimin Yue, Baimin Niu, Huizhen Sun, Xiaoqian Liu, Jue Wang and Jiaxin Chen

Chemical Engineering Journal, 2025, 519, 165093
DOI: 10.1016/j.cej.2025.165093

The gut-liver axis in fatty liver disease: role played by natural products

Zhu Ming, Xie Ruishi, Xu Linyi, Yang Yonggang, Luo Haoming and Lan Xintian

Front. Pharmacol., 2024, 15
DOI: 10.3389/fphar.2024.1365294

Targeting gut microbiota for diabetic nephropathy treatment: probiotics, dietary interventions, and fecal microbiota transplantation

Xiaoran Wang, Xinyin Liu, Fanghong Gong, Yan Jiang, Canwei Zhang, Wei Zhou and Wen Zhang

Front. Endocrinol., 2025, 16
DOI: 10.3389/fendo.2025.1621968

The cellular and molecular targets of natural products against metabolic disorders: a translational approach to reach the bedside

Xiaofei Shen, Hongling Yang, Yang Yang, Xianjun Zhu and Qingxiang Sun

MedComm, 2024, 5
DOI: 10.1002/mco2.664

Immunomodulatory Effects of Ganoderma lucidum Bioactive Compounds on Gut–Brain and Gut–Liver Axis Disorders

Liting Zhao, Zijun Geng, Ying Wang, Jiawei Wen and Da Liu

CIMB, 2025, 47, 842
DOI: 10.3390/cimb47100842

Baicalein alleviates hepatic lipid metabolism disorders via the PPARα-FGF21-adiponectin axis: Regulating crosstalk between the liver and adipose tissue

Qing-Song Xia, Yu Chen, Pan Shen, Jing Gong, Fu-Er Lu and Hong Chen

Journal of Ethnopharmacology, 2026, 367, 121676
DOI: 10.1016/j.jep.2026.121676

Dendrobium huoshanense Polysaccharide Improves High‐Fat Diet Induced Liver Injury by Regulating the Gut‐Liver Axis

Meng‐Hua Ma, Lei‐Lei Gao, Chuang‐Bo Chen, Fang‐li Gu, Si‐Qi Wu, Fang Li and Bang‐Xing Han

Chemistry & Biodiversity, 2023, 20
DOI: 10.1002/cbdv.202300980

Network Pharmacology, Molecular Docking Analysis and Molecular Dynamics Simulation of Scutellaria baicalensis in the Treatment of Liver Fibrosis

Junrui Wang, Zhuoqing Wu, Xiaolei Chen, Ying Sun, Shuyao Ma, Jingdan Weng, Yuxin Zhang, Keke Dong, Jiangjuan Shao and Shizhong Zheng

CPD, 2024, 30, 1326
DOI: 10.2174/0113816128297074240327090020

Duodenal mucosal ablation with irreversible electroporation reduces liver lipids in rats with non-alcoholic fatty liver disease

Jia-Wei Yu, Qi Zhao, Pei-Xi Li, Ya-Xuan Zhang, Bi-Xuan Gao, Lin-Biao Xiang, Xiao-Yu Liu, Lei Wang, Yi-Jie Sun, Ze-Zhou Yang, Yu-Jia Shi, Yun-Fei Chen, Meng-Bo Yu, Hong-Ke Zhang, Lei Zhang, Qin-Hong Xu, Lu Ren, Dan Li, Yi Lyu, Feng-Gang Ren and Qiang Lu

World J Gastroenterol, 2025, 31
DOI: 10.3748/wjg.v31.i16.105188

Fructose aggravating colon barrier dysfunction by decreasing gut bacteria metabolites indole-3-carboxaldehyde and inhibiting activation of aryl hydrocarbon receptor in vivo and in vitro

Ge Song, Shaojie Pang, Wenting Peng, Wei Fang, Yong Wang, Rui Liu, Qianyun Gan and Wentao Qi

Food Science and Human Wellness, 2025, 14, 9250094
DOI: 10.26599/FSHW.2024.9250094

Gut-Liver Axis: The Role of Intestinal Microbiota and Their Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease

Chao Cui, Shuai Gao, Jingfei Shi and Kai Wang

Gut and Liver, 2025, 19, 479
DOI: 10.5009/gnl240539

Si-Wu-Tang Targets Microbiota Homeostasis and Intestinal Mucosal Barriers to Provide Protection Against MASLD by Favoring P. goldsteinii-like Taxa Colonization

Xiaoyong Xue, Fukun Zhang, Hong Wang, Mengyu Guo, Wenqing Qin, Yun Yang, Zixuan Huo, Xin Li, Qi Han and Xiaojiaoyang Li

Pharmaceuticals, 2026, 19, 400
DOI: 10.3390/ph19030400

Soybean genistin-driven gut microbiota-derived butyrate synthesis activates the SIRT1 signaling pathway to ameliorate metabolic fatty liver

Guohui Yi, Wanying Sun, Xueer Zhang, Zhongtao Wang, Xiaodan Yu, Canyang Zhu and Kaiwen Lin

Free Radical Biology and Medicine, 2025, 239, 336
DOI: 10.1016/j.freeradbiomed.2025.07.053

Polysaccharide-based encapsulation systems: Prospective strategies for modulating the gut-brain axis and neuroprotection

Mengting Chen, Lijun Liu, Renyou Gan, Xiaojun Huang and Hui Ye

Trends in Food Science & Technology, 2025, 166, 105399
DOI: 10.1016/j.tifs.2025.105399

The pharmacological effects and therapeutic potential of flavonoids in digestive diseases

Junkang Xu, Jin Zhang, Bo Yu, Cuizhe Liu and Lin Zhang

Front. Pharmacol., 2026, 16
DOI: 10.3389/fphar.2025.1684377

Mechanism and interventions of the bile acid-gut-liver axis imbalance in the progression of non-alcoholic fatty liver disease

Ya-qi Guo, Chen-xi Jia, Tian-lu Zhu, Zhen Sun, Yu-ting Xi, Xing Liu, Chu-chu Li, Peng Li, Chang-zheng Li and Qian-qian Niu

Biochemical Pharmacology, 2026, 249, 117897
DOI: 10.1016/j.bcp.2026.117897

Research progress on the role and mechanism of traditional Chinese medicine based on "liver-multiple-organ interaction"

Chen Yang, Feng Xiang, Jingchen Xie, Zhimin Zhang, Bohou Xia, Yan Lin, Zhe Shi, Qinhui Tuo, Limei Lin and Yamei Li

Journal of Ethnopharmacology, 2026, 363, 121446
DOI: 10.1016/j.jep.2026.121446

First-in-class drug oroxylin A tablets for treating hepatic and gastrointestinal disorders: from preclinical development to clinical research

Chengju Luo, Xuhong Li, Yuan Gao, Junyi Yang, Weiming Fang and Libin Wei

Chinese Journal of Natural Medicines, 2025, 23, 801
DOI: 10.1016/S1875-5364(25)60910-1

Design of Coamorphous Systems for Flavonoid Components Coformed with Meglumine by Integrating Theory-Model-Experiment Techniques

Jiawei Han, Wen Sun, Jiaxin Chen, Zhimin Yue, Weitao Fang, Xiaoqian Liu, Jue Wang and Gaorong Wu

Mol. Pharmaceutics, 2025, 22, 3045
DOI: 10.1021/acs.molpharmaceut.4c01536

Baicalein Inhibits Tumor Property of Hepatocellular Carcinoma Cells Through the Inactivation of the E2F Transcription Factor 1/Mediator Complex Subunit 7 Axis

Pinghui Song, Naiying Shen, Zhongkun Wu and Sha He

Chem Biol Drug Des, 2025, 105
DOI: 10.1111/cbdd.70063

Pre-treatment with baicalein alleviates the diquat-induced microglial pyroptosis through gut microbiota–derived indole-3-propionic acid and DDX3X/G3BP1 pathway

Ting Li, Mengxiao Feng, Ping Wang, Miao Jiang, Jaiyu Cui, Mengxia Jin, Congying Song, Liying Lin and Yuan-Qiang Lu

Cell Biol Toxicol, 2026, 42
DOI: 10.1007/s10565-026-10189-w

Echinacea purpurea polysaccharide intervene in hepatocellular carcinoma via modulation of gut microbiota to inhibit TLR4/NF-κB pathway

Gaoxiang Jing, Wenqian Xu, Wei Ma, Qian Yu, Hongkang Zhu, Chang Liu, Yuliang Cheng, Yahui Guo and He Qian

International Journal of Biological Macromolecules, 2024, 261, 129917
DOI: 10.1016/j.ijbiomac.2024.129917

Flavonoids as functional food-derived modulators of the gut microbiota-NF-κB axis in metabolic dysfunction-associated steatotic liver disease

Lunasmrita Saikia, Partha Pratim Dutta, Douglas Law, Saikat Sen, Manish Kumar Gautam and Dhrubajyoti Gogoi

Mol Cell Biochem, 2026, 481, 2357
DOI: 10.1007/s11010-026-05549-3

Simiao Yongan decoction alleviates sepsis-induced liver injury by modulating macrophage polarization via gut-derived ursodeoxycholic acid

Ting Yu, Zhehong Liu, Yu Liu, Ming Gao, Fazhong Guo, Yanjuan Liu, Jun Xiong, Yu Jiang and Shifan Yan

Phytomedicine, 2026, 158, 158363
DOI: 10.1016/j.phymed.2026.158363

Association between dietary flavonoids intake and metabolic dysfunction-associated steatotic liver disease especially in non-smokers: a cross-sectional study in US adults

Linxiao Gao, Haoyu Fang, Yanhe Liu, Wen Luo, Jianping Gong and Rong Ma

BMC Gastroenterol, 2025, 25
DOI: 10.1186/s12876-025-04060-1